PURE BIOSCIENCE, INC. - 10-K Filing
PURE Bioscience, Inc. reports fiscal year ending July 31, 2026, with significant debt obligations and private placement activity.
Tickers: $PURE
Read the full article at SEC EDGAR
Part of the story Odyssey Health, Inc. - 10-K Filing (4 articles)